Prostatis Group LLC Organogenesis Holdings Inc. Transaction History

Prostatis Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 23, 2023	SELL	$9.02 - $13.5 $131,908 - $197,424	-14,624 Closed	0 $0
Q3 2021 Mar 23, 2023	SELL	$13.71 - $17.18 $33,520 - $42,005	-2,445 Reduced 14.32%	14,624 $14.6 Million
Q2 2021 Mar 23, 2023	SELL	$14.92 - $23.23 $24,513 - $38,166	-1,643 Reduced 8.78%	17,069 $17.1 Million
Q1 2021 Mar 23, 2023	BUY	$7.33 - $21.06 $137,158 - $394,074	18,712 New	18,712 $18.7 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prostatis Group LLC with notifications on news.